SCHEMBL3743740

SCHEMBL3743740

NC(=O)CSCc1c(Cl)cccc1Cl

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.65
HTT P42858 1/20 0.65
ALDH1A1 P00352 7/20 0.59
HPGD P15428 6/20 0.59
POLB P06746 1/20 0.59
KDM4E B2RXH2 1/20 0.58
GAA P10253 1/20 0.54
TP53 P04637 1/20 0.53
LMNA P02545 3/20 0.52
MAPT P10636 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.51
RECQL P46063 1/20 0.51
NPY1R P25929 1/20 0.51
NPY2R P49146 1/20 0.51
CYP3A4 P08684 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
CYP1A2 P05177 1/20 0.49
MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3142048 0.88 KDM4E (0.77) KMT2AHTTALDH1A1HPGDPOLB
SCHEMBL6375083 0.85 KDM4E (0.78) KMT2AHTTALDH1A1HPGDPOLB
SCHEMBL11271730 0.80 KMT2A (0.73) KMT2AHTTALDH1A1HPGDPOLB
SCHEMBL9456771 0.79 HTT (0.55) KMT2AHTTALDH1A1HPGDPOLB
SCHEMBL11271689 0.78 HTT (0.65) KMT2AHTTALDH1A1HPGDPOLB
SCHEMBL3979840 0.76 ALDH1A1 (0.48) KMT2AHTTALDH1A1POLBLMNA
SCHEMBL1395814 0.75 AKR1B1 (0.65) KMT2AALDH1A1LMNAMAPTRECQL
SCHEMBL11871473 0.74 KIF11 (0.49) KMT2AHTTALDH1A1HPGDPOLB
SCHEMBL11871475 0.74 KIF11 (0.49) KMT2AHTTALDH1A1HPGDPOLB
SCHEMBL2852938 0.74 TAAR1 (0.56) KMT2AALDH1A1LMNAMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7829568-B2 Substituted 5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-ylamine compounds and their use for producing drugs GRUENENTHAL GMBH (DE) 2010-11-09 US claimed
EP-1869038-B1 SUBSTITUTED 5,6,7,8-TETRAHYDRO-IMIDAZO[1,2-A]PYRIDIN-2-YLAMINE COMPOUNDS AND THEIR USE FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2009-07-08 EP claimed
US-20080300256-A1 Substituted 5,6,7,8-Tetrahydroimidazo[1,2-a]pyridin-2-ylamine Compounds and Their Use for Producing Drugs GRUENENTHAL GMBH (DE) 2008-12-04 US claimed
US-7829568-B2 Substituted 5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-ylamine compounds and their use for producing drugs GRUENENTHAL GMBH (DE) 2010-11-09 US disclosed
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-08-13 US disclosed
US-20080300256-A1 Substituted 5,6,7,8-Tetrahydroimidazo[1,2-a]pyridin-2-ylamine Compounds and Their Use for Producing Drugs GRUENENTHAL GMBH (DE) 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080300256-A1 Substituted 5,6,7,8-Tetrahydroimidazo[1,2-a]pyridin-2-ylamine Compounds and Their Use for Producing Drugs CYP3A7, CYP3A5, CYP2D6 KMT2A 2117/4885HTT 709/4885ALDH1A1 538/4885
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE FDPS, UMPS, GGPS1 KMT2A 4780/4885HTT 2977/4885ALDH1A1 3119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.